CIM Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,707
Closed -$481K 272
2022
Q4
$481K Sell
9,707
-240
-2% -$9.81K 0.19% 118
2022
Q3
$323K Buy
+9,947
New +$410K 0.14% 145
2020
Q2
Sell
-11,152
Closed -$647K 258
2020
Q1
$647K Buy
11,152
+302
+3% +$24.5K 0.32% 60
2019
Q4
$1M Buy
+10,850
New +$954K 0.4% 47

Other funds holding EXAS

CIM Investment Management's EXAS Position: Q1 2023 in Review

CIM Investment Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 9,707 shares — an estimated $481K sold.

CIM Investment Management first reported a position in EXAS in Q4 2019 and held it in 4 quarters. The position peaked at $1M in Q4 2019. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • CIM Investment Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • CIM Investment Management sold 9,707 Exact Sciences shares in Q1 2023, an estimated $481K.
  • CIM Investment Management first reported a position in Exact Sciences in Q4 2019 and held it in 4 quarters.
  • CIM Investment Management's Exact Sciences position peaked at $1M in Q4 2019.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on CIM Investment Management's 13F filing for Q1 2023, filed 16 May 2023.